Journal of Renal Nutrition
Volume 20, Issue 5 , Pages 329-333 , September 2010

Adherence to Fish Oil Intervention in Patients With Chronic Kidney Disease

  • Rachel Zabel, PhD

      Affiliations

    • Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland, Australia
    • Corresponding Author InformationAddress reprint requests to Rachel Zabel, PhD, School of Public Health, Queensland University of Technology, Victoria Park Road, Kelvin Grove, Queensland 4059, Australia.
    • ,
  • Susan Ash, PhD

      Affiliations

    • Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland, Australia
    • ,
  • Neil King, PhD

      Affiliations

    • Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland, Australia
    • ,
  • Judith Bauer, PhD

      Affiliations

    • Wesley Research Institute, Wesley Hospital, Auchenflower, Queensland, Australia

References 

  1. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–398
  2. Hamazaki T, Nakazawa R, Tateno S, et al. Effects of fish oil rich in eicosapentaenoic acid on serum lipid in hyperlipidemic hemodialysis patients. Kidney Int. 1984;26:81–84
  3. Griffith S. A review of the factors associated with patient compliance and the taking of prescribed medicines. Br J Gen Pract. 1990;40:114–116
  4. Zabel R, Ash S, Bauer J, King N. The effect of fish oil on novel inflammatory markers in hemodialysis patients. J Ren Nutr. 2008;18(Suppl):S26
  5. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40:373–383
  6. Fearon KCH, Von Meyenfeldt MF, Moses AGW, et al. Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: A randomised double blind trial. Gut. 2003;52:1479–1486
  7. Cleland LG, Proudman SM, Hall C, et al. A biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritis. Lipids. 2003;38:419–424
  8. Friedman A, Moe S, Perkins S, Li Y, Watkins B. Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. Am J Kidney Dis. 2006;47:1064–1071
  9. Saran R, Bragg-Gresham J, Rayner H, et al. Nonadherence in hemodialysis: Associations with mortality, hospitalisations and practice patterns in the DOPPS. Kidney Int. 2003;64:254–262
  10. Bame S, Petersen N, Wray N. Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med. 1993;37:1035–1043

 This work was conducted at the Wesley Research Institute, Wesley Hospital, Auchenflower, Queensland, Australia.

 Fish oil was supplied “in kind” by Nordic Naturals, Inc. (Watsonville, CA). Nordic Naturals, Inc., had no role in the study design, collection, analysis, or interpretation of data, writing of the manuscript, or in the decision to submit the manuscript for publication. There are no conflicts of interest to declare. R.Z. designed the study, collected the data, analyzed and interpreted the results, and wrote the manuscript. S.A., J.B., and N.K also designed the study, and assisted in the interpretation of results and writing of the manuscript. All authors read and approved the final manuscript.

PII: S1051-2276(10)00004-X

doi: 10.1053/j.jrn.2010.01.003

Journal of Renal Nutrition
Volume 20, Issue 5 , Pages 329-333 , September 2010

Article Tools

* Image Usage & Resolution